Skip to Content
MilliporeSigma
Get up to 22% off for Pi Day through March 27.Save Now

1134335

USP

Ciprofloxacin hydrochloride

United States Pharmacopeia (USP) Reference Standard

Synonym(s):

Ciprofloxacin hydrochloride monohydrate

Slide 1 of 1
Sign In to View Organizational & Contract Pricing.

Select a Size

400 MG

$455.00

$455.00

Available to ship TODAYDetails

​
Request a Bulk Order
​
Ships Every 4 weeks

About This Item

Empirical Formula (Hill Notation):
C17H18FN3O3 · HCl · H2O
CAS Number:
86393-32-0
Molecular Weight:
385.82
NACRES:
NA.24
PubChem Substance ID:
329749408
UNSPSC Code:
41116107
MDL number:
MFCD00242856

Key Documents

View All Documentation

Skip To

Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

InChI

1S/C17H18FN3O3.ClH.H2O/c18-13-7-11-14(8-15(13)20-5-3-19-4-6-20)21(10-1-2-10)9-12(16(11)22)17(23)24;;/h7-10,19H,1-6H2,(H,23,24);1H;1H2

SMILES string

O.Cl.OC(=O)C1=CN(C2CC2)c3cc(N4CCNCC4)c(F)cc3C1=O

InChI key

ARPUHYJMCVWYCZ-UHFFFAOYSA-N

grade

pharmaceutical primary standard

API family

ciprofloxacin

manufacturer/tradename

USP

application(s)

pharmaceutical (small molecule)

format

neat

Looking for similar products? Visit Product Comparison Guide

Related Categories

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
C2190000BP9291097636
Ciprofloxacin hydrochloride United States Pharmacopeia (USP) Reference Standard

USP

1134335

Ciprofloxacin hydrochloride

Ciprofloxacin hydrochloride European Pharmacopoeia (EP) Reference Standard

C2190000

Ciprofloxacin hydrochloride

Ciprofloxacin hydrochloride British Pharmacopoeia (BP) Reference Standard

BP929

Ciprofloxacin hydrochloride

USP

USP

1097636

Cefepime hydrochloride

grade

pharmaceutical primary standard

grade

pharmaceutical primary standard

grade

pharmaceutical primary standard

grade

pharmaceutical primary standard

manufacturer/tradename

USP

manufacturer/tradename

EDQM

manufacturer/tradename

BP

manufacturer/tradename

USP

format

neat

format

neat

format

neat

format

neat

application(s)

pharmaceutical (small molecule)

application(s)

pharmaceutical (small molecule)

application(s)

pharmaceutical
pharmaceutical small molecule

application(s)

pharmaceutical (small molecule)

API family

ciprofloxacin

API family

ciprofloxacin

API family

ciprofloxacin

API family

cefepime

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Other Notes

Sales restrictions may apply.

comparable product

Product No.
Description
Pricing

related product

Product No.
Description
Pricing

PHR1167

Ciprofloxacin, Pharmaceutical Secondary Standard; Certified Reference Material

PHR1174

Fluoroquinolonic acid, Pharmaceutical Secondary Standard; Certified Reference Material

1134324

Ciprofloxacin Ethylenediamine Analog, United States Pharmacopeia (USP) Reference Standard

1278302

Fluoroquinolonic acid, United States Pharmacopeia (USP) Reference Standard

Y0000198

Ciprofloxacin, European Pharmacopoeia (EP) Reference Standard

C2190050

Ciprofloxacin impurity A, European Pharmacopoeia (EP) Reference Standard

1134459

Ciprofloxacin formamide, United States Pharmacopeia (USP) Reference Standard

1134346

Ciprofloxacin Related Compound A, United States Pharmacopeia (USP) Reference Standard

1134313

Ciprofloxacin, United States Pharmacopeia (USP) Reference Standard

PHR2440

Ciprofloxacin formamide, certified reference material, pharmaceutical secondary standard

Storage Class

11 - Combustible Solids

flash_point_f

Not applicable

flash_point_c

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Lucile Pantel et al.
Antimicrobial agents and chemotherapy (2021-03-10)
NOSO-502 is a preclinical antibiotic candidate of the Odilorhabdin class. This compound exhibits activity against Enterobacteriaceae pathogens, including carbapenemase-producing bacteria and most of the Colistin (CST)-resistant strains. Among a collection of CST-resistant Klebsiella pneumoniae strains harboring mutations on genes pmrAB
Andrea Meyerhoff et al.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 39(3), 303-308 (2004-08-13)
In August 2000, the US Food and Drug Administration (FDA) approved ciprofloxacin hydrochloride (Cipro; Bayer) for management of postexposure inhalational anthrax. This was the first antimicrobial drug approved by the FDA for use in treating an infection due to a
Corinne N Thompson et al.
Tropical medicine & international health : TM & IH, 19(10), 1284-1292 (2014-07-30)
The country of Fiji, with a population of approximately 870 000 people, faces a growing burden of several communicable diseases including the bacterial infection typhoid fever. Surveillance data suggest that typhoid has become increasingly common in rural areas of Fiji
Rik Oldenkamp et al.
Chemosphere, 115, 88-94 (2014-02-11)
A methodology was developed for the assessment and comparison of the environmental impact of two alternative pharmaceutical prescriptions. This methodology provides physicians with the opportunity to include environmental considerations in their choice of prescription. A case study with the two
Ziyu Sun et al.
Infection and immunity, 82(4), 1638-1647 (2014-02-05)
Pseudomonas aeruginosa is an opportunistic pathogen that causes acute and chronic infections in humans. Pyocins are bacteriocins produced by P. aeruginosa that are usually released through lysis of the producer strains. Expression of pyocin genes is negatively regulated by PrtR
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service